Redmile Group, LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 59 filers reported holding OVID THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$137,000
-13.8%
40,6740.0%0.00%0.0%
Q2 2021$159,000
-67.6%
40,674
-66.6%
0.00%
-71.4%
Q1 2021$490,000
+73.8%
121,9500.0%0.01%
+133.3%
Q4 2020$282,000
-59.7%
121,9500.0%0.00%
-76.9%
Q3 2020$700,000
-22.1%
121,9500.0%0.01%
-23.5%
Q2 2020$899,000
+147.7%
121,9500.0%0.02%
+70.0%
Q1 2020$363,000
-28.3%
121,9500.0%0.01%
-16.7%
Q4 2019$506,000
+28.1%
121,9500.0%0.01%
-7.7%
Q3 2019$395,000
-71.0%
121,950
-83.5%
0.01%
-66.7%
Q2 2019$1,364,000
+4.5%
737,5500.0%0.04%
+2.6%
Q1 2019$1,305,000
-26.9%
737,5500.0%0.04%
-47.2%
Q4 2018$1,785,000
-56.9%
737,550
+1.0%
0.07%
-43.3%
Q3 2018$4,140,000
+335.3%
730,150
+498.7%
0.13%
+296.9%
Q2 2018$951,000
-16.3%
121,950
-24.1%
0.03%
-27.3%
Q1 2018$1,136,000
-63.2%
160,718
-48.6%
0.04%
-67.2%
Q4 2017$3,087,000
-18.1%
312,782
-30.7%
0.13%
-28.0%
Q3 2017$3,771,000
-11.0%
451,182
+0.5%
0.19%
-27.9%
Q2 2017$4,237,000448,7810.26%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders